Tuesday - May 13, 2025

Ibogaine Clinic Leadership Finalizes Conference Strategy, Emphasizes Personalized Treatment and Future Research

CORAL SPRINGS, FL – May 5, 2025 – Key leadership from Ibogaine Clinic, including Gavriel Dardashti, Cole Barressi, and Misty Huckabey, convened recently to strategically plan their participation in an upcoming industry conference. The meeting focused on optimizing the clinic’s … Continue reading

Paranormal Investigator Gary Arnold Releases Free Documentaries Exploring the Mystery of Electronic Voice Phenomena (EVP)

Oxford, Pennsylvania – Paranormal experiencer Gary Arnold has released two compelling short documentaries chronicling his ongoing investigation into Electronic Voice Phenomena (EVP) — mysterious voices captured during audio recordings that defy conventional explanation. Arnold believes these voices, which he calls … Continue reading

Gavriel Dardashti Details Ibogaine Protocol Enhancements, Joined by Neuroscientist Misty Huckabey, at 2025 Denver Psychedelic Conference

PLANTATION, FL – April 30, 2025 – Representing Ibogaine by David Dardashti, Gavriel Dardashti will detail significant neuroscientific advancements enhancing ibogaine therapy protocols at the influential 2025 Psychedelic Conference in Denver, Colorado. Building on the foundational work of his father, … Continue reading

Eosinophilic Esophagitis Drugs Market 2034: EMA, PDMA, FDA Approvals, Clinical Trials, Medication, Therapies, Prevalence, and Companies by DelveInsight

Eosinophilic Esophagitis Drugs Market Eosinophilic Esophagitis Companies are Regeneron Pharmaceuticals, Sanofi, Bristol-Myers Squibb, Ellodi Pharmaceuticals, AstraZeneca, Allakos, EsoCap AG, Pfizer, Ception Therapeutics, Celgene, Dr. Falk Pharma GmbH, Revolo Biotherapeutics, Shire, Novartis, EMS, Celgene, Oxagen Ltd, Meritage Pharma, Inc, Forest Laboratories, … Continue reading